SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-20-003014
Filing Date
2020-04-29
Accepted
2020-04-29 16:05:16
Documents
12
Period of Report
2020-06-16
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a_042920.htm DEF 14A 1018749
2 GRAPHIC logo.jpg GRAPHIC 11147
3 GRAPHIC colleran.jpg GRAPHIC 2297
4 GRAPHIC board.jpg GRAPHIC 79587
5 GRAPHIC blanchard.jpg GRAPHIC 9813
6 GRAPHIC bower.jpg GRAPHIC 7619
7 GRAPHIC land.jpg GRAPHIC 5365
8 GRAPHIC larsen.jpg GRAPHIC 5548
9 GRAPHIC thompson.jpg GRAPHIC 5885
10 GRAPHIC vogt.jpg GRAPHIC 10223
11 GRAPHIC proxy_01.jpg GRAPHIC 137063
12 GRAPHIC proxy_02.jpg GRAPHIC 183061
  Complete submission text file 0001171843-20-003014.txt   1642541
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14027 | Film No.: 20830232
SIC: 3841 Surgical & Medical Instruments & Apparatus